Section 36-11A-1 - Definitions.
36-11A-1. Definitions. Terms used in this chapter mean:
(1) "Authentication," to affirmatively verify before any wholesale distribution of a prescription drug occurs that each transaction listed on the pedigree has occurred;
(2) "Board," the State Board of Pharmacy;
(3) "Chain pharmacy warehouse," a physical location for prescription drugs that acts as a central warehouse and performs intracompany sales or transfers of such drugs to a group of chain pharmacies that have the same common ownership and control;
(4) Co-licensed partner," a party that, with another party or parties, has the right to engage in the manufacturing or marketing, or both, of a co-licensed product;
(5) "Co-licensed product," a prescription drug in which two or more parties have the right to engage in the manufacturing or marketing, or both, of a drug consistent with the federal Food and Drug Administration's implementation of the Prescription Drug Marketing Act (21 C.F.R. Parts 203 and 205);
(6) "Drug," "prescription drug," any drug, including any biological product, except for blood and blood components intended for transfusion or biological products that are also medical devices required by federal law or federal regulation to be dispensed only by a prescription, including finished dosage forms and bulk drug substances subject to § 503(b) of the Federal Food, Drug and Cosmetic Act;
(7) "Drug coupon," a form which may be redeemed at no cost or at reduced cost for a prescription drug;
(8) "Drug Enforcement Administration," the Drug Enforcement Administration of the United States Department of Justice;
(9) "Drug sample," a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug;
(10) "Facility," a facility of a wholesale distributor where prescription drugs are stored, handled, repackaged, or offered for sale;
(11) "Manufacturer," as defined by the federal Food and Drug Administration's regulations implementing the Prescription Drug Marketing Act (21 C.F.R. Parts 203 and 205);
(12) "Out-of-state wholesale drug distributor," a wholesale drug distributor with no physical facilities located in this state;
(13) "Pharmacy," a place registered by the board under chapter 36-11 in which prescription drugs are sold at retail;
(14) "Pedigree," a document or electronic file containing information that records each wholesale distribution of any given prescription drug;
(15) "Repackage," repackaging or otherwise changing the container, wrapper, or labeling to further the distribution of a prescription drug excluding that completed by the pharmacist responsible for dispensing the drug to the patient;
(16) "Repackager," a person who repackages.
Source: SL 1991, ch 307, § 1; SL 2007, ch 215, § 1.